Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 3Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 2Anemia 2Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma 1Fatigue 1Esophageal Neoplasms 1Breast Neoplasms 1

Interventions

Therapeutics 5Methylphenidate 3Exercise 3Sunitinib 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2isoquercitrin 1enzalutamide 1darolutamide 1apalutamide 1Transcranial Magnetic Stimulation 1Surveys and Questionnaires 1Sugars 1Qigong 1Nutritional Support 1Neurofeedback 1Methods 1Lactose 1High-Intensity Interval Training 1Epoetin Alfa 1Early Intervention, Educational 1Dexamethasone 1Darbepoetin alfa 1Creatine 1Counseling 1Cognitive Behavioral Therapy 1Acupuncture Therapy 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Epoetin Alfa × Genitourinary × Clear all
NCT00060398 2023-06-15

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
282 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡